Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
D015065:17-Hydroxycorticosteroids / Q000652:urine*; D000236:Adenoma / Q000150:complications* / Q000188:drug therapy; D000310:Adrenal Gland Neoplasms / Q000150:complications* / Q000188:drug therapy*; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D003480:Cushing Syndrome / Q000209:etiology*; D003907:Dexamethasone; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D008797:Metyrapone / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests
D015065:17-Hydroxycorticosteroids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D008797:Metyrapone